Zoetis | ZTS - Net Income

Stock Price
77.72
Daily Change
3.50 4.72%
Monthly
-36.67%
Yearly
-52.59%
Q2 Forecast
72.73

Zoetis reported $601M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AbbVie USD 695M 1.12B Mar/2026
Align Technology USD 112.77M 22.99M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Dentsply International USD -10M 136M Mar/2026
Eli Lilly USD 7.4B 760M Mar/2026
Henry Schein USD 107M 6M Mar/2026
Idexx Laboratories USD 278.45M 30.26M Mar/2026
Illumina USD 134M 200M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
J&J USD 5.24B 119M Mar/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Merck USD -4.24B 7.2B Mar/2026
Neogen USD -17M 1.08M Dec/2025
Pacira USD 2.92M 1.28M Mar/2026
Perrigo USD -398.6M 1.02B Mar/2026
Pfizer USD 2.69B 4.34B Mar/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Sanofi EUR 1.61B 2.42B Mar/2026
Sanofi EUR -801M 3.6B Dec/2025
Zoetis USD 601M 2M Mar/2026